1.55
price down icon2.52%   -0.04
after-market アフターアワーズ: 1.62 0.07 +4.52%
loading

Can-Fite Biopharma Ltd ADR (CANF) 最新ニュース

pulisher
Jan 10, 2025

Lenovo Integrates AI and Robotics to Deliver Smarter Retail Solutions - Business Wire

Jan 10, 2025
pulisher
Dec 07, 2024

Cronos Group Inc (NASDAQ: CRON) Could Slash -12.75% Soon - Stocks Register

Dec 07, 2024
pulisher
Dec 07, 2024

Commercial Metals Co (NYSE: CMC) Could Slash -1.03% Soon - Stocks Register

Dec 07, 2024
pulisher
Dec 04, 2024

Can Fite Biopharma stock hits 52-week low at $1.86 - Investing.com India

Dec 04, 2024
pulisher
Nov 11, 2024

Can-Fite Achieves Milestone with First Patient Dosing in Pancreatic Cancer Phase IIa Clinical Trial - GlobeNewswire Inc.

Nov 11, 2024
pulisher
Nov 04, 2024

Can-Fite secures Australian patent for obesity treatment - Investing.com

Nov 04, 2024
pulisher
Oct 28, 2024

Deutsche Bank Appointed as Depositary Bank for the Sponsored American Depositary Receipt Program of WeRide Inc. - Business Wire

Oct 28, 2024
pulisher
Oct 18, 2024

Can-Fite's partner Vetbiolix secures $325M deal for dog arthritis drug - Investing.com India

Oct 18, 2024
pulisher
Sep 25, 2024

Ratios in Focus: Analyzing Can-Fite Biopharma Ltd ADR (CANF)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Sep 25, 2024
pulisher
Sep 24, 2024

What is CANF’s price-to-sales ratio telling us about the company’s value? - US Post News

Sep 24, 2024
pulisher
Sep 02, 2024

Taking on analysts’ expectations and winning: Can-Fite Biopharma Ltd ADR (CANF) - SETE News

Sep 02, 2024
pulisher
Sep 02, 2024

Analytical Lens: Exploring Can-Fite Biopharma Ltd ADR (CANF)’s Financial Story Through Ratios - The Dwinnex

Sep 02, 2024
pulisher
Sep 02, 2024

CANF (Can-Fite Biopharma Ltd ADR) has impressive results - US Post News

Sep 02, 2024
pulisher
Aug 26, 2024

List of Israeli Stocks Traded on the NYSE Worth Considering - The Times of Israel

Aug 26, 2024
pulisher
Aug 23, 2024

Wearable Devices Ltd. sets annual meeting for September 26 - Investing.com

Aug 23, 2024
pulisher
Jul 17, 2024

Can-Fite BioPharma shares upgraded by EF Hutton to Buy on pipeline drugs - Investing.com

Jul 17, 2024
pulisher
Jun 28, 2024

Canine arthritis treatment shows promise in clinical study - Investing.com India

Jun 28, 2024
pulisher
Nov 21, 2023

symbol__ Stock Quote Price and Forecast - CNN

Nov 21, 2023
pulisher
Jul 12, 2023

Liver Cirrhosis Market to Observe Impressive Growth at a CAGR of 6.3% by 2032, Predicts DelveInsight - PR Newswire UK

Jul 12, 2023
pulisher
Dec 30, 2022

Can-Fite Announces ADS Ratio Change - Business Wire

Dec 30, 2022
pulisher
Nov 10, 2022

Catalyst's (CPRX) Q3 Earnings & Revenues Surpass Estimates - Nasdaq

Nov 10, 2022
pulisher
Oct 19, 2022

Le 1001 azioni che si sono schiantate sul mercato azionario USA - Scenari Economici

Oct 19, 2022
pulisher
Mar 16, 2021

Can-Fite Signs $42.7 Million Out-Licensing Deal with Ewopharma - Business Wire

Mar 16, 2021
pulisher
Sep 16, 2020

Can-Fite BioPharma (CANF) Stock Price, News & Analysis - MarketBeat

Sep 16, 2020
pulisher
Aug 24, 2019

10 Biopharmaceutical Companies Trying To Cure Cancer - Yahoo Finance

Aug 24, 2019
pulisher
Aug 02, 2016

Can-Fite's Rheumatoid Arthritis Drug Faces Off With Methotrexate In Phase III Trial For $40 Billion Market (NYSE:CANF) - Seeking Alpha

Aug 02, 2016
pulisher
Oct 04, 2012

Can-Fite BioPharma Begins Trading in U.S. through Launch of ADRs - CNBC

Oct 04, 2012
$30.75
price down icon 0.65%
$71.93
price down icon 0.75%
$19.03
price up icon 4.62%
$358.93
price down icon 2.04%
biotechnology ONC
$210.08
price up icon 2.31%
$111.93
price down icon 0.74%
大文字化:     |  ボリューム (24 時間):